Hiraoka M - Search Results

1

In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probe.

Fujita Y, Kuchimaru T, Kadonosono T, Tanaka S, Hase Y, Tomimoto H, Hiraoka M, Kizaka-Kondoh S, Ihara M, Takahashi R. Fujita Y, et al. Among authors: hiraoka m. PLoS One. 2012;7(10):e48051. doi: 10.1371/journal.pone.0048051. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094105 Free PMC article.

2

Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.

Harada H, Hiraoka M, Kizaka-Kondoh S. Harada H, et al. Among authors: hiraoka m. Cancer Res. 2002 Apr 1;62(7):2013-8. Cancer Res. 2002. PMID: 11929818

3

Tumor hypoxia: a target for selective cancer therapy.

Kizaka-Kondoh S, Inoue M, Harada H, Hiraoka M. Kizaka-Kondoh S, et al. Among authors: hiraoka m. Cancer Sci. 2003 Dec;94(12):1021-8. doi: 10.1111/j.1349-7006.2003.tb01395.x. Cancer Sci. 2003. PMID: 14662015 Free PMC article. Review.

4

Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites.

Inoue M, Mukai M, Hamanaka Y, Tatsuta M, Hiraoka M, Kizaka-Kondoh S. Inoue M, et al. Among authors: hiraoka m. Int J Oncol. 2004 Sep;25(3):713-20. Int J Oncol. 2004. PMID: 15289874

5

Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts.

Liu J, Qu R, Ogura M, Shibata T, Harada H, Hiraoka M. Liu J, et al. Among authors: hiraoka m. J Radiat Res. 2005 Mar;46(1):93-102. doi: 10.1269/jrr.46.93. J Radiat Res. 2005. PMID: 15802864 Free article.

6

Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals.

Harada H, Kizaka-Kondoh S, Hiraoka M. Harada H, et al. Among authors: hiraoka m. Mol Imaging. 2005 Jul-Sep;4(3):182-93. doi: 10.1162/15353500200505112. Mol Imaging. 2005. PMID: 16194450

7

Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment.

Harada H, Kizaka-Kondoh S, Hiraoka M. Harada H, et al. Among authors: hiraoka m. Breast Cancer. 2006;13(1):16-26. doi: 10.2325/jbcs.13.16. Breast Cancer. 2006. PMID: 16518058 Free article. Review.

8

Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element.

Kageyama Y, Sugiyama H, Ayame H, Iwai A, Fujii Y, Huang LE, Kizaka-Kondoh S, Hiraoka M, Kihara K. Kageyama Y, et al. Among authors: hiraoka m. Acta Oncol. 2006;45(3):317-24. doi: 10.1080/02841860500486648. Acta Oncol. 2006. PMID: 16644575

9

Mechanism of hypoxia-specific cytotoxicity of procaspase-3 fused with a VHL-mediated protein destruction motif of HIF-1alpha containing Pro564.

Harada H, Kizaka-Kondoh S, Hiraoka M. Harada H, et al. Among authors: hiraoka m. FEBS Lett. 2006 Oct 16;580(24):5718-22. doi: 10.1016/j.febslet.2006.09.025. Epub 2006 Sep 22. FEBS Lett. 2006. PMID: 17010341 Free article.

10

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hiraga T, et al. Among authors: hiraoka m. Cancer Res. 2007 May 1;67(9):4157-63. doi: 10.1158/0008-5472.CAN-06-2355. Cancer Res. 2007. PMID: 17483326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,278 results

Search Page

Filters